MDR1 Synonymous Polymorphisms Alter Transporter Specificity and Protein Stability in a Stable Epithelial Monolayer
- 15 January 2014
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (2) , 598-608
Abstract
The drug efflux function of P-glycoprotein (P-gp) encoded by MDR1 can be influenced by genetic polymorphisms, including two synonymous changes in the coding region of MDR1. Here we report that the conformation of P-gp and its drug efflux activity can be altered by synonymous polymorphisms in stable epithelial monolayers expressing P-gp. Several cell lines with similar MDR1 DNA copy number were developed and termed LLC-MDR1-WT (expresses wild-type P-gp), LLC-MDR1-3H (expresses common haplotype P-gp), and LLC-MDR1-3HA (a mutant that carries a different valine codon in position 3435). These cell lines express similar levels of recombinant mRNA and protein. P-gp in each case is localized on the apical surface of polarized cells. However, the haplotype and its mutant P-gps fold differently from the wild-type, as determined by UIC2 antibody shift assays and limited proteolysis assays. Surface biotinylation experiments suggest that the non-wild-type P-gps have longer recycling times. Drug transport assays show that wild-type and haplotype P-gp respond differently to P-gp inhibitors that block efflux of rhodamine 123 or mitoxantrone. In addition, cytotoxicity assays show that the LLC-MDR1-3H cells are more resistant to mitoxantrone than the LLC-MDR1-WT cells after being treated with a P-gp inhibitor. Expression of polymorphic P-gp, however, does not affect the host cell's morphology, growth rate, or monolayer formation. Also, ATPase activity assays indicate that neither basal nor drug-stimulated ATPase activities are affected in the variant P-gps. Taken together, our findings indicate that “silent” polymorphisms significantly change P-gp function, which would be expected to affect interindividual drug disposition and response. Cancer Res; 74(2); 598–608. ©2013 AACR.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- A synonymous polymorphic variation in ACADM exon 11 affects splicing efficiency and may affect fatty acid oxidationMolecular Genetics and Metabolism, 2013
- Strong Purifying Selection at Synonymous Sites in D. melanogasterPLOS Genetics, 2013
- ATP-Binding Cassette Transporter Expression in Human Placenta as a Function of Pregnancy ConditionDrug Metabolism and Disposition, 2011
- Inhibition of Multidrug Resistance-Linked P-Glycoprotein (ABCB1) Function by 5′-Fluorosulfonylbenzoyl 5′-Adenosine: Evidence for an ATP Analogue That Interacts with Both Drug-Substrate-and Nucleotide-Binding SitesBiochemistry, 2011
- Synonymous but not the same: the causes and consequences of codon biasNature Reviews Genetics, 2010
- A Dual-Fluorescence High-Throughput Cell Line System for Probing Multidrug ResistanceASSAY and Drug Development Technologies, 2009
- A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein functionBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Synonymous Mutations and Ribosome Stalling Can Lead to Altered Folding Pathways and Distinct MinimaJournal of Molecular Biology, 2008
- Ethnicity-Related Polymorphisms and Haplotypes in the HumanABCB1GenePharmacogenomics, 2006
- P-glycoprotein-mediated renal tubular secretion of digoxin: The toxicological significance of the urine-blood barrier modelLife Sciences, 1993